Kuros Biosciences AG (CSBTF)

PNK: CSBTF · Real-Time Price · USD

34.00

1.60 (4.94%)

At close: May 02, 2025, 12:15 PM

Kuros Biosciences Balance Sheet Statement

Financials in CHF. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	17.46M	14.21M	24.07M	28.62M	28.39M	20.8M	18.33M	16.67M	12.37M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	51.05M	53.46M	60.1M	62.52M	n/a	-1.38M	15K
Other Long-Term Assets	n/a	651K	-51.05M	-58.44M	-60.1M	-64.56M	-1.82M	38K	15K
Receivables	14.93M	6.41M	2.82M	1.69M	1.04M	759K	214K	154K	308K
Inventory	9.44M	4.86M	3.17M	1.76M	1.46M	954K	547K	220K	276K
Other Current Assets	2.92M	1.21M	801K	356K	2.54M	316K	413K	364K	373K
Total Current Assets	44.75M	27.19M	31.39M	32.89M	33.97M	23.29M	19.83M	17.67M	13.4M
Property-Plant & Equipment	3.02M	2.64M	2.32M	2.45M	2.59M	2.78M	634K	630K	45K
Goodwill & Intangibles	34.42M	40.98M	48.73M	56M	57.51M	61.78M	65.35M	67.78M	30.31M
Total Long-Term Assets	39.78M	44.27M	51.55M	58.44M	60.4M	64.56M	65.99M	68.41M	30.37M
Total Assets	84.54M	71.46M	82.95M	91.34M	94.36M	87.85M	85.82M	86.08M	43.77M
Account Payables	6.91M	1.3M	1.3M	846K	936K	1.06M	1.61M	1.32M	1.27M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	13.46M	3.44M	5.91M	6.53M	69K	48K	n/a	206K	n/a
Total Current Liabilities	20.9M	13.19M	12.59M	11.29M	3.88M	3.64M	4.04M	4.66M	3.27M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	3.3M	n/a	n/a	1.24M	3.83M	4.21M	5.3M	8.29M	2.18M
Total Long-Term Liabilities	4.89M	1.56M	1.5M	3.07M	5.89M	6.36M	5.3M	8.29M	2.18M
Total Liabilities	25.79M	14.75M	14.09M	14.36M	9.76M	10M	9.34M	12.94M	5.45M
Total Debt	1.79M	2.14M	1.91M	2.15M	2.34M	2.39M	n/a	n/a	n/a
Common Stock	3.79M	3.68M	3.66M	3.28M	32.81M	22.47M	15.06M	8.17M	5.08M
Retained Earnings	-45.43M	-42.5M	-116.25M	-101.17M	-93.15M	-81.9M	-69.43M	-57.16M	-43.34M
Comprehensive Income	n/a	n/a	20.9M	20.71M	21.02M	20.06M	20.52M	20.7M	15.93M
Shareholders Equity	58.75M	56.71M	68.86M	76.98M	84.6M	77.86M	76.48M	73.14M	38.32M
Total Investments	n/a	16.51M	51.05M	53.46M	60.1M	62.52M	n/a	-1.38M	15K